Robot-Assisted Radical Prostatectomy Using the KangDuo Surgical Robot-01 System: A Prospective, Single-Center, Single-Arm Clinical Study
- PMID: 35442762
- PMCID: PMC12721627
- DOI: 10.1097/JU.0000000000002498
Robot-Assisted Radical Prostatectomy Using the KangDuo Surgical Robot-01 System: A Prospective, Single-Center, Single-Arm Clinical Study
Erratum in
-
Robot-Assisted Radical Prostatectomy Using the KangDuo Surgical Robot-01 System: A Prospective, Single-Center, Single-Arm Clinical Study.J Urol. 2022 Sep;208(3):744. doi: 10.1097/JU.0000000000002838. Epub 2022 Sep 1. J Urol. 2022. PMID: 35942793 No abstract available.
Abstract
Purpose: Our goal was to evaluate the feasibility, safety and effectiveness of the KangDuo Surgical Robot-01 (KD-SR-01) system for robot-assisted radical prostatectomy (RARP).
Materials and methods: This prospective, single-center, single-arm clinical study was conducted from May 2021 to August 2021. Sixteen RARP procedures with the KD-SR-01 system were performed by 1 surgeon. The perioperative and followup data were prospectively recorded. Early oncologic outcomes were assessed according to surgical margin status and continence was defined as no more than 1 pad daily or urine leakage of ≤20 gm by the 24-hour pad weight test. Ergonomics were assessed with the NASA-TLX (National Aeronautics and Space Administration Task Load Index).
Results: All cases were completed successfully without conversion to traditional RARP, laparoscopic surgery or open surgery. The median docking time, console time and urethrovesical anastomosis time were 5.9 (range, 2.5-11.5), 87 (range, 70-120) and 14.4 minutes (range, 12.0-25.7), respectively. The median estimated blood loss was 50 ml (range, 10-200). None of patients required intraoperative transfusion. The median postoperative hospital stay was 5 days (range, 4-10). Overall, a positive surgical margin occurred in 4 (25%) patients. No biochemical recurrence occurred within 1 month after surgery. The continence rate was 87.5% (14/16) at 1 month after catheter removal. No severe intraoperative or postoperative complications (Clavien-Dindo grade ≥3) occurred. The surgeon reported a high comfort level with a NASA-TLX global score of 22.7±3.2.
Conclusions: The KD-SR-01 system is feasible, safe and effective for management of localized prostate cancer.
Keywords: prostatic neoplasms; robotic surgical procedures; robotics.
Conflict of interest statement
Conflict of Interest: Cui Liang is the co-founder and stock owner of Suzhou KangDuo Robot Co., Ltd. All other authors have nothing to declare.
Figures
Comment in
-
Editorial Comment.J Urol. 2022 Jul;208(1):127. doi: 10.1097/JU.0000000000002498.02. Epub 2022 May 18. J Urol. 2022. PMID: 35442763 No abstract available.
-
Editorial Comment.J Urol. 2022 Jul;208(1):126-127. doi: 10.1097/JU.0000000000002498.01. Epub 2022 May 18. J Urol. 2022. PMID: 35442764 No abstract available.
-
Robotic Urologic Oncologic Surgery: Ever-Widening Horizons.J Urol. 2022 Jul;208(1):8-9. doi: 10.1097/JU.0000000000002752. Epub 2022 May 10. J Urol. 2022. PMID: 35536680 No abstract available.
References
-
- Zincke H, Oesterling JE, Blute ML, et al. : Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol 1994; 152: 1850. - PubMed
-
- Schuessler WW Schulam PC and Clayman RV: Laparoscopic radical prostatectomy: initial case report. J Urol 1992; 147: 246. - PubMed
-
- Wirth GJ, Psutka SP, Chapin BF, et al. : Midterm oncological outcomes of laparoscopic vs open radical prostatectomy (RP). BJU Int 2013; 112: 190. - PubMed
-
- Poulakis V, Witzsch U, de Vries R, et al. : Laparoscopic radical prostatectomy in men older than 70 years of age with localized prostate cancer: comparison of morbidity, reconvalescence, and short-term clinical outcomes between younger and older men. Eur Urol 2007; 51: 1341. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
